Literature DB >> 33362267

Novel CRISPR-based sequence specific enrichment methods for target loci and single base mutations.

Jennifer L Steele1, Richard C Stevens1, Oscar A Cabrera1, Gary J Bassill1, Sabrina M Cramer1, Felipe Guzman1, Anthony P Shuber1.   

Abstract

The programmable sequence specificity of CRISPR has found uses in gene editing and diagnostics. This manuscript describes an additional application of CRISPR through a family of novel DNA enrichment technologies. CAMP (CRISPR Associated Multiplexed PCR) and cCAMP (chimeric CRISPR Associated Multiplexed PCR) utilize the sequence specificity of the Cas9/sgRNA complex to target loci for the ligation of a universal adapter that is used for subsequent amplification. cTRACE (chimeric Targeting Rare Alleles with CRISPR-based Enrichment) also applies this method to use Cas9/sgRNA to target loci for the addition of universal adapters, however it has an additional selection for specific mutations through the use of an allele-specific primer. These three methods can produce multiplex PCR that significantly reduces the optimization required for every target. The methods are also not specific to any downstream analytical platform. We additionally will present a mutation specific enrichment technology that is non-amplification based and leaves the DNA in its native state: TRACE (Targeting Rare Alleles with CRISPR-based Enrichment). TRACE utilizes the Cas9/sgRNA complex to sterically protect the ends of targeted sequences from exonuclease activity which digests both the normal variant as well as any off-target sequences.

Entities:  

Mesh:

Year:  2020        PMID: 33362267      PMCID: PMC7757808          DOI: 10.1371/journal.pone.0243781

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  60 in total

Review 1.  Overview of Target Enrichment Strategies.

Authors:  Iwanka Kozarewa; Javier Armisen; Andrew F Gardner; Barton E Slatko; C L Hendrickson
Journal:  Curr Protoc Mol Biol       Date:  2015-10-01

2.  Next-generation DNA sequencing.

Authors:  Jay Shendure; Hanlee Ji
Journal:  Nat Biotechnol       Date:  2008-10       Impact factor: 54.908

Review 3.  Current companion diagnostics in advanced colorectal cancer; getting a bigger and better piece of the pie.

Authors:  Jonathan M Loree; Scott Kopetz; Kanwal P S Raghav
Journal:  J Gastrointest Oncol       Date:  2017-02

Review 4.  Implementing Genome-Driven Oncology.

Authors:  David M Hyman; Barry S Taylor; José Baselga
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

5.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

Review 6.  Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies.

Authors:  Stanislav Volik; Miguel Alcaide; Ryan D Morin; Colin Collins
Journal:  Mol Cancer Res       Date:  2016-07-15       Impact factor: 5.852

7.  Analysis of short tandem repeat expansions and their methylation state with nanopore sequencing.

Authors:  Pay Giesselmann; Björn Brändl; Etienne Raimondeau; Rebecca Bowen; Christian Rohrandt; Rashmi Tandon; Helene Kretzmer; Günter Assum; Christina Galonska; Reiner Siebert; Ole Ammerpohl; Andrew Heron; Susanne A Schneider; Julia Ladewig; Philipp Koch; Bernhard M Schuldt; James E Graham; Alexander Meissner; Franz-Josef Müller
Journal:  Nat Biotechnol       Date:  2019-11-18       Impact factor: 54.908

8.  RNase H-dependent PCR (rhPCR): improved specificity and single nucleotide polymorphism detection using blocked cleavable primers.

Authors:  Joseph R Dobosy; Scott D Rose; Kristin R Beltz; Susan M Rupp; Kristy M Powers; Mark A Behlke; Joseph A Walder
Journal:  BMC Biotechnol       Date:  2011-08-10       Impact factor: 2.563

Review 9.  Next-generation sequencing: advances and applications in cancer diagnosis.

Authors:  Simona Serratì; Simona De Summa; Brunella Pilato; Daniela Petriella; Rosanna Lacalamita; Stefania Tommasi; Rosamaria Pinto
Journal:  Onco Targets Ther       Date:  2016-12-02       Impact factor: 4.147

10.  CRISPR/Cas9-targeted enrichment and long-read sequencing of the Fuchs endothelial corneal dystrophy-associated TCF4 triplet repeat.

Authors:  Nathaniel J Hafford-Tear; Yu-Chih Tsai; Amanda N Sadan; Beatriz Sanchez-Pintado; Christina Zarouchlioti; Geoffrey J Maher; Petra Liskova; Stephen J Tuft; Alison J Hardcastle; Tyson A Clark; Alice E Davidson
Journal:  Genet Med       Date:  2019-02-08       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.